Loading...
Loading...
All product recalls affecting Pennsylvania.
Includes nationwide recalls (tagged “Nationwide”) and recalls with Pennsylvania in the distribution area.
Potential breach of sterile barrier packaging.
cGMP deviations and lack of assurance of sterility.
cGMP deviations and lack of assurance of sterility.
Ford Motor Company (Ford) is recalling certain 2023 F-150 Lightning vehicles. The fasteners that secure the junction box bus bars inside the high-voltage battery pack may not have been tightened securely, which can cause electrical arcing at the busbars.
cGMP deviations and lack of assurance of sterility.
cGMP deviations and lack of assurance of sterility.
cGMP deviations and lack of assurance of sterility.
Ford Motor Company (Ford) is recalling certain 2025 F-150 vehicles. The air bag warning label may be missing from the dashboard. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 208, "Occupant Crash Protection."
Firm has received an increase in reports regarding inadvertent instrument lockout during surgical procedures involving the device. If lockout occurs, the device will momentarily activate but will not cut or staple tissue, and additional steps will be required to open it and remove it from tissue. If user is unable to remove the device from the tissue, potential harms to patient include surgical delay, bleeding/hemorrhage, life threatening hemorrhage/hemorrhagic shock, and conversion to open therapy. Two adverse events received, including one patient death.
Internal testing found that Plum Duo pumps with software version 1.1.1 have a workflow that may result in bypassing the Maximum Dose Limit alert. The Maximum Dose Limit is set in the LifeShield Drug Library Manager (DLM) within the LifeShield Medication Management Safety Software and specifies the highest dose at which the pump can be programmed for weight or BSA (body surface area) based medication rulesets. The limit can be configured for Dose, Loading Dose, and Bolus Dose.
Software issue with scanning equipment that can results in the filed rotation not being applied correctly.
Shyft Group (Shyft) is recalling certain 2022-2025 Utilimaster Aeromaster Upfit vehicles. The suspension seat mounting fasteners may have been improperly tightened. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard (FMVSS) number 207, "Seating Systems."
International Motors, LLC (International) is recalling certain 2025-2026 IC CESB and 2025 EVSB school buses. The driver's seat belt anchor bolt may come loose.
Dorel Juvenile Group (Dorel) is recalling certain Safety 1st Grow & Go Sprint child seats. The included model numbers are CC321GYU, CC321GYUD, CC321GYY, CC321GYYD, CC321HAO, and CC321HAR. The headrest foam pad is not adequately secured, which can allow a child to pick off pieces of foam.
Alliance RV, LLC (Alliance) is recalling certain 2025 Benchmark 42LFT travel trailers, equipped with a removable step assembly. The clip-on bracket mounting bolts may come loose, allowing the steps to detach.
Notice was issued to clarify flow rates related to the inlet fluid temperature.
CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
Internal testing found that Plum Duo pumps with software version 1.1.1 have a workflow that may result in bypassing the Maximum Dose Limit alert. The Maximum Dose Limit is set in the LifeShield Drug Library Manager (DLM) within the LifeShield Medication Management Safety Software and specifies the highest dose at which the pump can be programmed for weight or BSA (body surface area) based medication rulesets. The limit can be configured for Dose, Loading Dose, and Bolus Dose.
Blue Bird Bus Company (Blue Bird) is recalling certain 2022-2024 Vision electric school buses equipped with hydraulic brakes. The system software may fail to detect and alert the driver to a loss of the secondary brake assist.
Test results for cast padding component included in procedure trays shows Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals exceeded residual limits, which may lead to a possible loss or lack of functionality that may lead to a delay or prolonged treatment/procedure/therapy.